24/06/2026
Worried that long-term heartburn tablets could raise your risk of stomach cancer? Reassuring news.
A large study across five Nordic countries, published in The BMJ, found no link between long-term use of PPIs (common acid-reflux medicines) and stomach cancer. The same held for another class of acid-reducing drugs.
It's observational research with some caveats, so never change medication without speaking to your GP — but it's a reassuring result for the many people who rely on these treatments. Read more:
A large Nordic study found no link between long-term PPI use and stomach cancer. Here's what the research shows about PPIs and stomach cancer — and the caveats.